Ginkgo Bioworks (DNA) to Release Quarterly Earnings on Thursday

Ginkgo Bioworks (NYSE:DNA) is projected to announce its earnings results after the market closes on Thursday, March 6th. Analysts expect the company to announce earnings of ($1.45) per share and revenue of $44.43 million for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

Ginkgo Bioworks Price Performance

Shares of DNA opened at $9.16 on Thursday. Ginkgo Bioworks has a 52-week low of $5.26 and a 52-week high of $64.40. The company has a 50 day simple moving average of $11.53. The firm has a market capitalization of $526.45 million, a P/E ratio of -0.70 and a beta of 1.16.

Ginkgo Bioworks Company Profile

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.